|
1) Jennette JC, Hipp CG. C1q nephropathy: a distinct pathologic entity usually causing nephrotic syndrome. Am J Kidney Dis. 1985; 6: 103-10
|
|
|
|
2) Jennette JC, Hipp CG. Immunohistopathologic evaluation of C1q in 800 renal biopsy speci-mens. Am J Clin Pathol. 1985; 83: 415-20
|
|
|
|
|
|
3) Iskandar SS, Browning MC, Lorentz WB. C1q nephropathy: a pediatric clinicopathologic study. Am J Kidney Dis. 1991; 18: 459-65
|
|
|
|
|
|
4) Davenport A, Maciver AG, Mackenzie JC. C1q nephropathy: do C1q deposits have any prognostic significance in the nephrotic syndrome？ Nephrol Dial Transpl. 1992; 7: 391-6
|
|
|
|
|
|
5) Markowitz GS, Schwimmer JA, Stokes MB, et al. C1q nephropathy: a variant of segmental glomerulosclerosis. Kidney Int. 2003; 64: 1232-40
|
|
|
|
|
6) Lau KK, Gaber LW, Santos NMD, et al. C1q nephropathy: features at presentation and outcome. Pediatr Nephrol. 2005; 20: 744-9
|
|
|
|
|
|
7) Nishida M, Kawakatsu H, Okumura Y, et al. C1q nephropathy with asymptomatic urine abnormal-ities. Pediatr Nephrol. 2005; 20: 1669-70
|
|
|
|
|
|
8) Levart TK, Kenda RB, Cavic MA, et al. C1q nephropathy in children. Pediatr Nephrol. 2005; 20: 1756-61
|
|
|
|
|
|
9) Hisano S, Uesugi N, Iwasaki H. Clinico-pathological correlation in C1q nephropathy (abstract). The annual meeting of Am Soc Nephrol; Philadelphia, USA: 2005
|
|
|
|
|
|
10) Fukuma Y, Hisano S, Segawa Y, et al. Clinicopathological correlation of C1q nephrop-athy in children. Am J Kidney Dis. 2006; 47: 412-8
|
|
|
|
|
|
11) Yoshikawa N, Ito H, Sakai T, et al. A controlled trial of combined therapy for newly diagnosed severe childhood IgA nephropathy. J Am Soc Nephrol. 1999; 10: 101-9
|
|
|
|
|
|
12) Hisano S, Matsushita M, Fujita T, et al. Activation of lectin complement pathway in C1q nephrop-athy (abstract). The meeting of Am Soc Nephrol; San Diego; USA: 2006
|
|
|
|
|